Episode 497: Retatrutide Delivers Stunning Weight Loss Results In Triumph-1 Study
Heart Doc VIP with Dr. Joel KahnShow Notes
In this episode of HeartDoc VIP, Dr. Joel Kahn breaks down the newly released — but not yet fully published — results from the highly anticipated Triumph-1 study on retatrutide, an investigational weight loss medication that's already generating major buzz in the cardiometabolic world. The reported weight loss results at 80 and 104 weeks are remarkable, with side effects appearing consistent with other medications in this class, including semaglutide and tirzepatide. Dr. Kahn discusses what's known so far, what questions still remain, and why the full peer-reviewed publication is so important before drawing final conclusions on risks and benefits. FDA approval may not be far away. Other topics in this packed episode include the troubling rise in fatal heart attacks among younger adults, a modified Mediterranean diet linked to lower diabetes risk, the connection between food preservatives and heart disease, atrial fibrillation in athletes, nitric oxide's role in brain health, fatty liver disease and cardiovascular risk, and how the American Heart Association's Life's Essential 8 score may predict diabetes risk in women. Thanks to Igennus for sponsoring this episode. Visit their site and use promo code DRKAHN to save on high-quality supplements.
More from Heart Doc VIP with Dr. Joel Kahn
Exercise is one of the most powerful tools we have to protect our heart health at every stage of life. This week, Dr. Kahn explores a new statement from the American College of Cardiology emphasizing the importance of physical activity throughout our lives. Sadly, fewer than 20% of teens meet the criteria for optimal cardiovascular health, highlighting a major opportunity to make movement and exercise a bigger part of everyday life in our schools and workplaces. The benefits go far beyond the heart—from head to toe!
This week, Dr. Kahn presents the case of a patient seen this month at the Kahn Center for Cardiac Longevity who, over the course of five years, has reversed artery aging and plaque and is enjoying excellent health. He discusses the program used to achieve these benefits. This case, along with many others from the Kahn Center, offers hope for maintaining youthful arteries throughout your life.
This week, Dr. Kahn presents a new scientific statement by the American College of Cardiology on nutrition to prevent heart disease. The emphasis is on plant-based choices while limiting red meat, processed foods, and excess added sugar. Sometimes, hearing the same recommendation over and over can help.
This week, as a bonus, Dr. Kahn interviews a Detroit clothing legend, Phil, who celebrated his 100th birthday recently by buying a new sports car! He is approaching his 78th wedding anniversary with his beautiful wife. He discussed his early days in business and early successes, and his health journey, relying a lot on the education he got by repeatedly visiting the Pritikin Longevity Center.
This week, Dr. Kahn brings back the topic of Mankai Duckweed, the smallest edible plant, which provides a complete protein profile, >200 polyphenols, B12, choline, folate, Omega-3s, and other nutrients. Mankai was previously available as a frozen cube but has returned to the market as a user-friendly powder. Mankai is available here: partners.eatmankai.com/AA-DRKAHN